By enhancing insulin sensitivity and providing powerful appetite regulation, these therapies help reset the metabolic environment, making weight loss achievable again
its effects are parallel to the injectable form, offering convenience in weight management
Dumitrascu European Journal of Clinical Investigation .2026;[Epub] CrossRef Predictive factors of metabolic dysfunction associated steatotic liver disease (MASLD) among individuals with cardio-metabolic risk factors, multicenter cross-sectional study, North East Ethiopia Getachew Bizuneh Aydagnuhm, Aklile Semu Tefera, Gebru Tesfaw Getahun, Ermiyas Endewunet Melaku BMC Gastroenterology .2026;[Epub] CrossRef Temporal trends and racial/ethnic disparities in hepatocellular carcinoma incidence in the US between 2000-2022 Wenzhan Jing, Hang Pham, Samuel So JHEP Reports .2026
In June 2023, the FDA issued a warning that unapproved versions of GLP-1 drugs "can be risky for patients, as unapproved versions do not undergo FDAs review for safety, effectiveness and quality before they are marketed." The GLP-1 drug market has been dominated by pharmaceutical giant Novo Nordisk